Impact of Parenteral Glutamine Supplement on Oncologic Outcomes in Patients with Nasopharyngeal Cancer Treated with Concurrent Chemoradiotherapy

Impact of Parenteral Glutamine Supplement on Oncologic Outcomes in Patients with Nasopharyngeal Cancer Treated with Concurrent Chemoradiotherapy

Background: Oral mucositis (OM) is a common toxic side effect in nasopharyngeal carcinoma (NPC) patients receiving concurrent chemoradiotherapy (CCRT) that has a negative impact on treatment outcomes and patients’ survival. Our study aimed to evaluate the impact of parenteral glutamine supplement (d...

Full description

Bibliographic Details
Main Authors: Chih-Chun Wang, Tzer-Zen Hwang, Chuan-Chien Yang, Ching-Feng Lien, Chien-Chung Wang, Yu-Chen Shih, Shyh-An Yeh, Meng-Che Hsieh
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Nutrients
Subjects:
nasopharyngeal carcinoma
chemoradiotherapy
glutamine
dipeptiven
oncologic outcomes
oral mucositis
Online Access:https://www.mdpi.com/2072-6643/14/5/997

Internet

https://www.mdpi.com/2072-6643/14/5/997

Similar Items